ReviewMolecular biology reports2025
Research progress on how mesenchymal stem cells regulate hematopoietic stem cell behavior.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mesenchymal stem cells (MSCs) generate various stromal cells in the hematopoietic stem cell (HSCs) niche. As a major components of the HSC niche, multiple subpopulations of MSCs have been identified so far. MSCs can serve as an important cell therapy to facilitate hematopoietic stem cell transplantation (HSCT). Their use facilitates ex vivo expansion of HSCs, hematopoietic engraftment, and stimulation of residual hematopoietic tissues to restore hematopoiesis. In the bone marrow microenvironment, MSCs control HSC survival, proliferation, migration, and differentiation through close contact, secretion of soluble factors, and regulation of differentiation states. MSC-derived extracellular vesicles (EVs) are a prominent intercellular communication pathway, containing bioactive factors such as proteins, lipids, and miRNAs. Similar to MSCs, they regulate the fate of HSCs and represent a promising adjunctive therapeutic tool for HSCT. Furthermore, intercellular communication between MSCs and HSCs is modulated by diverse signaling pathways and gene expression. A growing number of studies have explored the mechanisms by which MSCs regulate HSCs, but further studies are needed to clarify the underlying mechanisms. Here, we reviewed the research progress on the mechanisms by which MSCs regulate HSCs. A deeper understanding of the MSC-HSC interaction network not only reveals the fundamental principles for maintaining hematopoietic homeostasis but also provides new insights for optimizing HSCT and treating bone marrow failure diseases.
Indexed as
Identifiers
41460546What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.